Canaccord Genuity Starts Aptose Biosciences (APTO) at Buy
Tweet
Share
E-mailGet Alerts APTO Hot Sheet
Price: $1.71 --0%
Rating Summary:
10 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 9 | New: 13
Rating Summary:
10 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 9 | New: 13
Join SI Premium – FREE
Canaccord Genuity initiated coverage on Aptose Biosciences (NASDAQ: APTO) with a Buy rating and a price target of $13.00.
For an analyst ratings summary and ratings history on Aptose Biosciences click here. For more ratings news on Aptose Biosciences click here.
Shares of Aptose Biosciences closed at $7.00 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wolfe Research Starts AFLAC (AFL) at Underperform
- BMO Capital Starts Perspective Therapeutics Inc (CATX) at Outperform
- BMO Capital Starts Alnylam Pharmaceuticals (ALNY) at Outperform
Create E-mail Alert Related Categories
Hot New Coverage, New CoverageRelated Entities
Canaccord GenuitySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
